+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Blood Glucose Monitoring Market by Product (Continuous Blood Glucose Monitors, Self or One Time Monitors), Testing Technology (Electrode Type Blood Glucose Monitor, Photoelectric Blood Glucose Monitor), Application, Distribution Channel, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666055
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Monitoring Market grew from USD 13.06 billion in 2023 to USD 14.08 billion in 2024. It is expected to continue growing at a CAGR of 8.28%, reaching USD 22.80 billion by 2030.

This practice helps in making informed decisions regarding diet, exercise, and medication, contributing to the effective management of blood sugar levels and reducing the risk of diabetes-related complications. The expansion of its use is primarily driven by the growing prevalence of diabetes globally, advancements in technology that provide more convenient and less invasive monitoring options, increased awareness about the importance of glycemic control, and the development of integrated care models. However, discomfort and pain related to frequent finger-prick tests, the cost of monitoring supplies, and the potential for inaccurate readings due to user error or device malfunction impact the product adoption. Manufacturers are focusing on developing continuous glucose monitors (CGMs) that offer painless, real-time monitoring while reducing user involvement, as well as investing in smart devices that can integrate with mobile technology for enhanced data tracking and analysis. The future opportunities in blood glucose monitoring are abundant, with prospects of non-invasive techniques, artificial intelligence (AI) for predictive analytics, and interconnected healthcare devices that could contribute to a more personalized and efficient diabetes management landscape.

Regional Insights

In the Americas, blood glucose monitoring devices are widely used, owing to the increasing prevalence of diabetes, particularly in the United States, which has a mature market for diabetes care. The production of these systems in this region is characterized by high technological innovation, stringent regulatory oversight, and substantial investments in research and development. Major companies based in the Americas provide advanced monitoring systems, including continuous glucose monitoring (CGM) devices and flash glucose monitoring systems. On the other hand, in the Asia-Pacific (APAC) region, there is rapid growth in the blood glucose monitoring market, fueled by the rising diabetic population, growing healthcare awareness, and improving healthcare infrastructure, particularly in emerging economies such as China and India. Production in APAC tends to focus on cost-effectiveness and accessibility, with international companies expanding their footprint to capture the burgeoning demand. Western Europe shows a strong demand for innovative and non-invasive monitoring technologies similar to the Americas, while the Middle East and Africa are emerging markets with a focus on basic glucose monitoring systems due to cost constraints and varying levels of healthcare infrastructure. Companies in the EMEA region are working to strive to balance between introducing advanced products and catering to affordability in different parts of the region.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Blood Glucose Monitoring Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Prevalence of diabetes and improved awareness programs
  • Increasing preference for non-invasive blood glucose monitoring technology
  • Need for continuous blood glucose monitoring in-home care settings

Market Restraints

  • Adverse recalls of blood glucose monitoring systems

Market Opportunities

  • Advancements in design and capabilities of blood glucose monitoring systems
  • Enhancements in the reimbursements for blood glucose monitoring

Market Challenges

  • Complexity in the production and operation of blood glucose monitoring

Market Segmentation Analysis

  • Product: Provision of personalized guidance in self-monitoring blood glucose monitors
  • Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
  • Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
  • End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Blood Glucose Monitoring Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Blood Glucose Monitoring Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Abbott Completes Acquisition Of Bigfoot Biomedical

Abbott completed its acquisition of Bigfoot Biomedical, a company offering smart insulin management technologies for diabetes patients. This strategic move amplifies Abbott's influence in the diabetes sector, enhancing its acclaimed FreeStyle Libre continuous glucose monitoring suite and bolstering its ambition to deliver highly personalized, precise diabetes management solutions.

Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin

Dexcom announced the innovation of a new device specifically tailored for individuals with type 2 diabetes who do not require insulin therapy. In recognition of the diverse coverage landscape, Dexcom is also introducing a cash-pay alternative, ensuring accessibility for those without Medicare or private insurance support, thereby advancing its mission to provide comprehensive diabetes care and bolster day-to-day treatment empowerment.

Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar

Astellas Pharma Inc. announced a strategic partnership with Roche Diabetes Care Japan to develop and commercialize a cutting-edge blood glucose monitoring system. This collaboration integrates Roche's Accu-Chek Guide Me system, known for its superior accuracy, with Welldoc's FDA-cleared BlueStar, an innovative digital health solution for individuals with diabetes. By joining forces, the two organizations aim to address the significant healthcare needs of the approximately 10 million Japanese people battling diabetes and prediabetes.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Blood Glucose Monitoring Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Monitoring Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AdvaCare Pharma, Advin Health Care, ARKRAY, Inc., Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation, B. Braun Melsungen AG, BAYER AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd., GlySens Incorporated, I-SENS, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., LifeScan IP Holding, LLC., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Nipro Europe Group Companies, Nova Biomedical, Novo Nordisk A/s, NXP Semiconductors N.V., PHC Holding Corporation, Prodigy Diabetes Care LLC, Sanofi S.A., Senseonics Holdings Inc., Sinocare Inc., Teladoc Health, Inc., Terumo Corporation, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Monitoring Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product- Continuous Blood Glucose Monitors

  • Insulin Pumps
  • Sensors
  • Transmitter & Receiver

Self or One Time Monitors

  • Blood Glucose Meter
  • Lancets
  • Testing Strips

Testing Technology

  • Electrode Type Blood Glucose Monitor
  • Photoelectric Blood Glucose Monitor

Application

  • Gestational Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes

Distribution Channel

  • Offline
  • Online

End-User

  • Home Care
  • Hospital & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of diabetes and improved awareness programs
5.1.1.2. Increasing preference for non-invasive blood glucose monitoring technology
5.1.1.3. Need for continuous blood glucose monitoring in-home care settings
5.1.2. Restraints
5.1.2.1. Adverse recalls of blood glucose monitoring systems
5.1.3. Opportunities
5.1.3.1. Advancements in design and capabilities of blood glucose monitoring systems
5.1.3.2. Enhancements in the reimbursements for blood glucose monitoring
5.1.4. Challenges
5.1.4.1. Complexity in the production and operation of blood glucose monitoring
5.2. Market Segmentation Analysis
5.2.1. Product: Provision of personalized guidance in self-monitoring blood glucose monitors
5.2.2. Testing Technology: Potential of electrode-type blood glucose monitors to be developed as portable and home-use devices
5.2.3. Application: Need for sophisticated CGMs with accuracy and constant monitoring for type-1 diabetes
5.2.4. End-User: Provision of blood glucose monitors that optimize clinical efficiency and patient throughput in hospitals
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Blood Glucose Monitoring Market, by Product
6.1. Introduction
6.2. Continuous Blood Glucose Monitors
6.3. Self or One Time Monitors
7. Blood Glucose Monitoring Market, by Testing Technology
7.1. Introduction
7.2. Electrode Type Blood Glucose Monitor
7.3. Photoelectric Blood Glucose Monitor
8. Blood Glucose Monitoring Market, by Application
8.1. Introduction
8.2. Gestational Diabetes
8.3. Type 1 Diabetes
8.4. Type 2 Diabetes
9. Blood Glucose Monitoring Market, by Distribution Channel
9.1. Introduction
9.2. Offline
9.3. Online
10. Blood Glucose Monitoring Market, by End-User
10.1. Introduction
10.2. Home Care
10.3. Hospital & Clinics
11. Americas Blood Glucose Monitoring Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Blood Glucose Monitoring Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Blood Glucose Monitoring Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Abbott Completes Acquisition Of Bigfoot Biomedical
14.3.2. Dexcom Announces Novel Wearable For Managing Type 2 Diabetes - Without Insulin
14.3.3. Astellas and Roche Diabetes Care Japan Ink Partnership Agreement To Develop And Commercialize Integrated Diabetes Self-Management Solution with BlueStar
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. BLOOD GLUCOSE MONITORING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD GLUCOSE MONITORING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BLOOD GLUCOSE MONITORING MARKET DYNAMICS
FIGURE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BLOOD GLUCOSE MONITORING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. BLOOD GLUCOSE MONITORING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BLOOD GLUCOSE MONITORING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TRANSMITTER & RECEIVER, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY BLOOD GLUCOSE METER, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY LANCETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING STRIPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ELECTRODE TYPE BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PHOTOELECTRIC BLOOD GLUCOSE MONITOR, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BLOOD GLUCOSE MONITORING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 82. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 83. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. ARGENTINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 91. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 92. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 93. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 96. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 97. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. BRAZIL BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 100. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 101. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 102. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 103. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 104. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 105. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 106. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 107. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. CANADA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 116. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 118. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 120. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. MEXICO BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 130. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 131. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 132. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 133. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 142. UNITED STATES BLOOD GLUCOSE MONITORING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 146. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 148. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 154. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 155. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. ASIA-PACIFIC BLOOD GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 160. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 161. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 162. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 163. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 164. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 165. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 166. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 167. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 170. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 171. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 172. AUSTRALIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 173. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 174. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 175. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 176. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 177. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 178. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 179. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 180. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 181. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. CHINA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 190. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 191. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 192. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 193. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. INDIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 202. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 203. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 204. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 205. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 206. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 207. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 208. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 209. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. INDONESIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 218. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 219. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 220. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 221. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 222. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 223. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. JAPAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 232. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 233. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 234. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 235. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 240. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 241. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. MALAYSIA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 246. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 247. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 248. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 249. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 250. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 251. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. PHILIPPINES BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 258. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 259. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 260. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 261. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 262. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 263. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. SINGAPORE BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 274. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 275. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 276. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 277. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 278. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 279. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 282. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 283. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. SOUTH KOREA BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 286. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 287. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 288. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 289. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 290. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 291. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 294. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 295. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. TAIWAN BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2018-2023 (USD MILLION)
TABLE 302. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY CONTINUOUS BLOOD GLUCOSE MONITORS, 2024-2030 (USD MILLION)
TABLE 303. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2018-2023 (USD MILLION)
TABLE 304. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY SELF OR ONE TIME MONITORS, 2024-2030 (USD MILLION)
TABLE 305. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 306. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY TESTING TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 307. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. THAILAND BLOOD GLUCOSE MONITORING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. VIETNAM BLOOD GLUCOSE MONITORING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AdvaCare Pharma
  • Advin Health Care
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG by PHC Holdings Corporation
  • B. Braun Melsungen AG
  • BAYER AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlySens Incorporated
  • I-SENS, Inc.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • LifeScan IP Holding, LLC.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Nipro Europe Group Companies
  • Nova Biomedical
  • Novo Nordisk A/s
  • NXP Semiconductors N.V.
  • PHC Holding Corporation
  • Prodigy Diabetes Care LLC
  • Sanofi S.A.
  • Senseonics Holdings Inc.
  • Sinocare Inc.
  • Teladoc Health, Inc.
  • Terumo Corporation
  • Ypsomed AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 14.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.8 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal

Related Topics

Related Reports

Global Continuous Blood Glucose Monitoring Systems Market by Product (Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems), Component (CGM Monitor, CGM Transmitter, Glucose Sensor), Testing Site, Patient Care Setting, Application - Forecast 2024-2030 - Product Image

Global Continuous Blood Glucose Monitoring Systems Market by Product (Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems), Component (CGM Monitor, CGM Transmitter, Glucose Sensor), Testing Site, Patient Care Setting, Application - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Blood Glucose Monitoring Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 110 Pages
  • Global
From
Global Blood Glucose Monitoring Devices Market Outlook, 2028 - Product Image

Global Blood Glucose Monitoring Devices Market Outlook, 2028

  • Report
  • 190 Pages
  • Global
From
Continuous Glucose Monitoring Device Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis By Product, Application, Testing Site, End User, and Geography - Product Image

Continuous Glucose Monitoring Device Market Size and Forecasts 2020 - 2030, Global and Regional Share, Trend, and Growth Opportunity Analysis By Product, Application, Testing Site, End User, and Geography

  • Report
  • 150 Pages
  • Global
From

About the Market

The Blood Glucose Monitoring market is a subset of the Glucose Testing market, which is used to measure the amount of glucose in the blood. Blood Glucose Monitoring is used to diagnose and monitor diabetes, as well as to assess the effectiveness of diabetes treatments. It is also used to monitor glucose levels in people with other medical conditions, such as kidney disease. Blood Glucose Monitoring is typically done using a glucometer, which is a device that measures the amount of glucose in a sample of blood. The glucometer is usually used in conjunction with a test strip, which is a disposable strip that is used to collect a sample of blood. Some companies in the Blood Glucose Monitoring market include Abbott Laboratories, Roche Diagnostics, LifeScan, and Ascensia Diabetes Care. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.